RESUMO
Patients with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) have better responses to radiotherapy and higher overall survival rates than do patients with HPV-negative HNSCC, but the mechanisms underlying this phenomenon are unknown. p16 is used as a surrogate marker for HPV infection. Our goal was to examine the role of p16 in HPV-related favorable treatment outcomes and to investigate the mechanisms by which p16 may regulate radiosensitivity. HNSCC cells and xenografts (HPV/p16-positive and -negative) were used. p16-overexpressing and small hairpin RNA-knockdown cells were generated, and the effect of p16 on radiosensitivity was determined by clonogenic cell survival and tumor growth delay assays. DNA double-strand breaks (DSBs) were assessed by immunofluorescence analysis of 53BP1 foci; DSB levels were determined by neutral comet assay; western blotting was used to evaluate protein changes; changes in protein half-life were tested with a cycloheximide assay; gene expression was examined by real-time polymerase chain reaction; and data from The Cancer Genome Atlas HNSCC project were analyzed. p16 overexpression led to downregulation of TRIP12, which in turn led to increased RNF168 levels, repressed DNA damage repair (DDR), increased 53BP1 foci and enhanced radioresponsiveness. Inhibition of TRIP12 expression further led to radiosensitization, and overexpression of TRIP12 was associated with poor survival in patients with HPV-positive HNSCC. These findings reveal that p16 participates in radiosensitization through influencing DDR and support the rationale of blocking TRIP12 to improve radiotherapy outcomes.
Assuntos
Carcinoma de Células Escamosas/radioterapia , Carcinoma de Células Escamosas/virologia , Proteínas de Transporte/metabolismo , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Neoplasias de Cabeça e Pescoço/radioterapia , Neoplasias de Cabeça e Pescoço/virologia , Papillomaviridae/fisiologia , Infecções por Papillomavirus/radioterapia , Ubiquitina-Proteína Ligases/metabolismo , Animais , Biomarcadores Tumorais , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/metabolismo , Proteínas de Transporte/genética , Linhagem Celular Tumoral , Inibidor p16 de Quinase Dependente de Ciclina/genética , Neoplasias de Cabeça e Pescoço/genética , Neoplasias de Cabeça e Pescoço/metabolismo , Humanos , Camundongos , Papillomaviridae/genética , Infecções por Papillomavirus/metabolismo , Tolerância a Radiação , Distribuição Aleatória , Carcinoma de Células Escamosas de Cabeça e Pescoço , Transfecção , Ubiquitina-Proteína Ligases/genética , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
Hormone suppression given before or after cytotoxic treatment stimulates the recovery of spermatogenesis from endogenous and transplanted spermatogonial stem cells (SSC) and restores fertility in rodents. To test whether the combination of hormone suppression and transplantation could enhance the recovery of spermatogenesis in primates, we irradiated (7 Gy) the testes of 12 adult cynomolgus monkeys and treated six of them with gonadotropin-releasing hormone antagonist (GnRH-ant) for 8 weeks. At the end of this treatment, we transfected cryopreserved testicular cells with green fluorescent protein-lentivirus and autologously transplanted them back into one of the testes. The only significant effect of GnRH-ant treatment on endogenous spermatogenesis was an increase in the percentage of tubules containing differentiated germ cells (tubule differentiation index; TDI) in the sham-transplanted testes of GnRH-ant-treated monkeys compared with radiation-only monkeys at 24 weeks after irradiation. Although transplantation alone after irradiation did not significantly increase the TDI, detection of lentiviral DNA in the spermatozoa of one radiation-only monkey indicated that some transplanted cells colonized the testis. However, the combination of transplantation and GnRH-ant clearly stimulated spermatogenic recovery as evidenced by several observations in the GnRH-ant-treated monkeys receiving transplantation: (i) significant increases (~20%) in the volume and weight of the testes compared with the contralateral sham-transplanted testes and/or to the transplanted testes of the radiation-only monkeys; (ii) increases in TDI compared to the transplanted testes of radiation-only monkeys at 24 weeks (9.6% vs. 2.9%; p = 0.05) and 44 weeks (16.5% vs. 6.1%, p = 0.055); (iii) detection of lentiviral sequences in the spermatozoa or testes of five of the GnRH-ant-treated monkeys and (iv) significantly higher sperm counts than in the radiation-only monkeys. Thus hormone suppression enhances spermatogenic recovery from transplanted SSC in primates and may be a useful tool in conjunction with spermatogonial transplantation to restore fertility in men after cancer treatment.
Assuntos
Hormônio Liberador de Gonadotropina/antagonistas & inibidores , Antagonistas de Hormônios/farmacologia , Oligopeptídeos/farmacologia , Espermatogênese/efeitos dos fármacos , Espermatogônias/transplante , Animais , Células Germinativas/transplante , Macaca fascicularis , Masculino , Camundongos , Contagem de Espermatozoides , Espermatogônias/citologia , Testículo/citologia , Testículo/efeitos da radiação , Transplante HeterólogoRESUMO
A new approach to intraoperative radiation therapy led to the development of mobile linear electron accelerators that provide lower electron energy beams than the usual conventional accelerators commonly encountered in radiotherapy. Such mobile electron accelerators produce electron beams that have nominal energies of 4, 6, 9 and 12 MeV. This work compares the absorbed dose output calibrations using both the AAPM TG-51 and TG-21 dose calibration protocols for two types of ion chambers: a plane-parallel (PP) ionization chamber and a cylindrical ionization chamber. Our results indicate that the use of a 'Markus' PP chamber causes 2-3% overestimation in dose-output determination if accredited dosimetry-calibration laboratory based chamber factors (N(60Co)(D,w,) Nx) are used. However, if the ionization chamber factors are derived using a cross-comparison at a high-energy electron beam, then a good agreement is obtained (within 1%) with a calibrated cylindrical chamber over the entire energy range down to 4 MeV. Furthermore, even though the TG-51 does not recommend using cylindrical chambers at the low energies, our results show that the cylindrical chamber has a good agreement with the PP chamber not only at 6 MeV but also down to 4 MeV electron beams.
Assuntos
Radioterapia/instrumentação , Radioterapia/métodos , Calibragem , Radioisótopos de Cobalto , Elétrons , Íons , Aceleradores de Partículas , Radiometria/instrumentação , Radiometria/métodos , ÁguaRESUMO
The Radiological Physics Center (RPC) is a resource to the medical physics community for assistance regarding dosimetry procedures. Since the publication of the AAPM TG-51 calibration protocol, the RPC has responded to numerous phone calls raising questions and describing areas in the protocol where physicists have had problems. At the beginning of the year 2000, the RPC requested that institutions participating in national clinical trials provide the change in measured beam output resulting from the conversion from the TG-21 protocol to TG-51. So far, the RPC has received the requested data from approximately 150 of the approximately 1300 institutions in the RPC program. The RPC also undertook a comparison of TG-21 and TG-51 and determined the expected change in beam calibration for ion chambers in common use, and for the range of photon and electron beam energies used clinically. Analysis of these data revealed two significant outcomes: (i) a large number (approximately 1/2) of the reported calibration changes for photon and electron beams were outside the RPC's expected values, and (ii) the discrepancies in the reported versus the expected dose changes were as large as 8%. Numerous factors were determined to have contributed to these deviations. The most significant factors involved the use of plane-parallel chambers, the mixing of phantom materials and chambers between the two protocols, and the inconsistent use of depth-dose factors for transfer of dose from the measurement depth to the depth of dose maximum. In response to these observations, the RPC has identified a number of circumstances in which physicists might have difficulty with the protocol, including concerns related to electron calibration at low energies (R50<2 cm), and the use of a cylindrical chamber at 6 MeV electrons. In addition, helpful quantitative hints are presented, including the effect of the prescribed lead filter for photon energy measurements, the impact of shifting the chamber depth for photon depth-dose measurements, and the impact of updated stopping-power data used in TG-51 versus that used in TG-21, particularly for electron calibrations.
Assuntos
Elétrons , Erros Médicos/instrumentação , Erros Médicos/normas , Serviço Hospitalar de Oncologia/normas , Serviço Hospitalar de Oncologia/tendências , Fótons , Radioterapia de Alta Energia/normas , Radioterapia de Alta Energia/tendências , Calibragem/normas , Protocolos Clínicos , Ensaios Clínicos como Assunto , Humanos , National Institutes of Health (U.S.) , Estados UnidosRESUMO
In the past, the Radiological Physics Center (RPC) has developed standard sets of photon depth-dose and wedge-factor data, specific to the make, model, and wedge design of the linear accelerator (linac). In this paper, the RPC extends the same concept to electron-cone ratios. Since 1987, the RPC has measured and documented cone-ratio (CR) values during on-site dosimetry review visits to institutions participating in National Cancer Institute cooperative clinical trials. Data have been collected for approximately 500 electron beams from a wide spectrum of linac models. The analysis presented in this paper indicates that CR values are predictable to 2% to 3% (two standard deviations) for a given make and model of linac with a few exceptions. The analysis also revealed some other interesting systematics. For some models, such as the Varian Clinac 2500 and the Elekta/Philips SL18, SL20, and SL25, CR values were nearly identical for cone sizes 15 cm x 15 cm (or 14 cm x 14 cm) and 20 cm x 20 cm across the range of available energies. Certain models of the same make of linac, such as the Mevatron MD, KD, and 6700 series models or the Clinac 2100 and 2300 models, exhibited indistinguishable CRs. Irrespective of linac model, two consistent general trends were observed: namely, an increase in CR value with incident beam energy for cone sizes smaller than 10 cm x 10 cm and a decrease with energy for cone sizes larger than 10 cm x 10 cm. These data are valuable to the RPC as a quality assurance remote-monitoring tool to identify potential dosimetry errors. The physics community will also find the data useful in several ways: as a redundant check for clinical values in use, to validate the values measured during commissioning of new machines or to ensure consistency of values measured during annual quality assurance procedures.
Assuntos
Elétrons , Aceleradores de Partículas/normas , Elétrons/uso terapêutico , Erros Médicos/prevenção & controle , Aceleradores de Partículas/classificação , Aceleradores de Partículas/instrumentação , Imagens de Fantasmas , Valor Preditivo dos Testes , Garantia da Qualidade dos Cuidados de Saúde/métodos , Planejamento da Radioterapia Assistida por ComputadorRESUMO
Task Group 51 (TG51), of the Radiation Therapy Committee of the American Association of Physicists in Medicine (AAPM), has developed a calibration protocol for high-energy photon and electron therapy beams based on absorbed dose standards. This protocol is intended to replace the air-kerma based protocol developed by an earlier AAPM task group (TG21). Conversion to the newer protocol introduces a change in the determined absorbed dose. In this work, the change in dose is expressed as the ratio of the doses (TG51/TG21) based on the two protocols. Dose is compared at the TG-51 reference depths of 10 cm for photons and d(ref) for electrons. Dose ratios are presented for a variety of ion chambers over a range of photon and electron energies. The TG51/TG21 dose ratios presented here are based on the dosimetry factors provided by the two protocols and the chamber-specific absorbed dose and exposure calibration factors (N60Co(D,w) and Nx) provided by the Accredited Dosimetry Calibration Laboratory (ADCL) at The University of Texas, M. D. Anderson Cancer Center (MDACC). As such, the values presented here represent the expected discrepancies between the two protocols due only to changes in the dosimetry parameters and the differences in chamber-specific dose and air-kerma standards. These values are independent of factors such as measurement uncertainties, setup errors, and inconsistencies arising from the mix of different phantoms and ion chambers for the two protocols. Therefore, these ratios may serve as a guide for institutions performing measurements for the switch from TG21-to-TG51 based calibration. Any significant deviation in the ratio obtained from measurements versus those presented here should prompt a review to identify possible errors and inconsistencies. For all cylindrical chambers included here, the TG51/TG21 dose ratios are the same within +/-0.6%, irrespective of the make and model of the chamber, for each photon and electron beam included. Photon beams show the TG51/TG21 dose ratios decreasing with energy, whereas electrons exhibit the opposite trend. The dose ratio for photons is near 1.00 at 18 mV increasing to near 1.01 at 4 mV while the dose ratio for electrons is near 1.02 at 20 MeV decreasing only 0.5% to near 1.015 at 6 MeV. For parallel-plate chambers, the situation is complicated by the two possible methods of obtaining calibration factors: through an ADCL or through a cross-comparison with a cylindrical chamber in a high-energy electron beam. For some chambers, the two methods lead to significantly different calibration factors, which in turn lead to significantly different TG51/TG21 results for the same chamber. Data show that if both N60Co(D,w) and Nx are obtained from the same source, namely an ADCL or a cross comparison, the TG51/TG21 results for parallel-plate chambers are similar to those for cylindrical chambers. However, an inconsistent set of calibration factors, i.e., using N60Co(D,w) x k(ecal) from an ADCL but Ngas from a cross comparison or vice versa, can introduce an additional uncertainty up to 2.5% in the TG51/TG21 dose ratios.
Assuntos
Monitoramento de Radiação/instrumentação , Monitoramento de Radiação/métodos , Radiometria/normas , Radioterapia de Alta Energia/instrumentação , Radioterapia de Alta Energia/métodos , Radioterapia/instrumentação , Calibragem , Elétrons , Humanos , Íons , Modelos Teóricos , Fótons , Dosagem Radioterapêutica , Reprodutibilidade dos TestesRESUMO
This report specifically describes the use of a unique anthropomorphic breast phantom to validate the accuracy of three-dimensional dose calculations performed by a commercial treatment-planning system for intact-breast tangential irradiation. The accuracy of monitor-unit calculations has been corroborated using ionization chamber measurements made in this phantom. Measured doses have been compared to those calculated from a variety of treatment plans. The treatment plans utilized a 6-MV x-ray beam and incorporated a variety of field configurations and wedge combinations. Dose measurements at several clinically relevant points within the breast phantom have confirmed the accuracy of calculated doses generated from the variety of treatment plans. Overall agreement between measurements and calculations averaged 0.998+/-0.009. These results indicate that the dose per monitor-unit calculations performed by the treatment-planning system can be confidently utilized in the fulfillment of clinical dose prescriptions.
Assuntos
Neoplasias da Mama/radioterapia , Imageamento Tridimensional/métodos , Imagens de Fantasmas , Planejamento da Radioterapia Assistida por Computador/instrumentação , Planejamento da Radioterapia Assistida por Computador/métodos , Tomografia Computadorizada por Raios X/métodos , Feminino , Humanos , Monitoramento de Radiação , Dosagem RadioterapêuticaRESUMO
A key component of the Radiological Physics Center's (RPC) on-site dosimetry review visits are photon beam calibrations for which determination of the energy of the x ray is a key element. The ratio of ionizations, TPR20/TPR10, for a 10 cm x 10 cm field at depths of 20 and 10 cm for a constant SCD is used as a quantitative measure of beam quality in the Task Group 21 protocol. The RPC has measured both TPR20/TPR10 and the corresponding ratio of percent depth dose (D20/D10) at a constant SSD for 685 photon beams (4-25 MV) for most makes and models if accelerators. A strong correlation between TPR20/TPR10 and D20/D10 is presented which allows the determination of the TPR ratio from the measurement of the ratio of percent depth doses. An analysis of the uncertainty introduced in the TG-21 factors (L/rho, Pwall, Prepl) caused by the spread in the measured data and translated into the determination of the TPR ratio results in an insignificant error (< 0.3%). This empirical relationship provides an alternate technique for quantifying the beam quality defined in the TG-21 protocol without surrendering any loss of precision in output calibration. This technique may be found by those who calibrate at a fixed SSD to be an easier and quicker method.
Assuntos
Modelos Biológicos , Fótons , Doses de Radiação , Calibragem , Imagens de Fantasmas , Dosagem Radioterapêutica , Radioterapia de Alta Energia/instrumentação , Raios XRESUMO
Cooperative clinical trial group protocols frequently require off-axis point dose calculations. The Radiological Physics Center uses the calculative technique developed by Hanson et al. [Med. Phys. 7, 145-146 (1980); 7, 147-150 (1980)] to verify these calculations. In order to correct for off-axis energy changes, this technique requires off-axis half-value layer data, HVL, as a function of off-axis ray angle for the specific beam. This paper presents a formulism based on HVL mesurements on a limited number of therapy beams, which allows the calculation of an off-axis energy-correction factor for any clinical photon beam created by a linear accelerator using conventional flattening filters.
Assuntos
Imagens de Fantasmas , Fótons , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador , Protocolos Clínicos , Desenho de Equipamento , Humanos , Aceleradores de Partículas , PoliestirenosRESUMO
Ionization chambers are frequently moved from one environment to another, sometimes with significant differences in temperature between the chamber and measurement phantom. To obtain reliable ionization data, the temperature of the air in the chamber must be allowed to equilibrate with the measuring phantom. The air temperature inside a thimble of a Farmer-type ion chamber was measured as a function of time for various phantom materials (air, water, and plastic). Equilibration rates for the various conditions are presented. Heat-diffusion theory is presented to explain the characteristics of the measured data. Waiting times for temperature equilibration down to 10% of the initial temperature difference ranges from 1 to 18 min, depending on the phantom material and use of bare or covered thimble. Radiation measurements confirm the temperature data.
Assuntos
Imagens de Fantasmas , Planejamento da Radioterapia Assistida por Computador/instrumentação , Radioterapia/instrumentação , Desenho de Equipamento , Humanos , Cinética , Modelos Teóricos , Plásticos , Poliestirenos , Dosagem Radioterapêutica , Temperatura , Fatores de TempoRESUMO
The Radiological Physics Center, through its dosimetry review visits to participating institutions, is aware that many institutions ignore the field-size and depth dependence of wedge transmission values. Reference wedge transmission values are normally measured by the Radiological Physics Center for a 10 cm x 10 cm field at the calibration depth of 5 or 7 cm. Recently, additional measurements (1) for a 10 cm x 10 cm field at 20-cm depth and (2) for a 20 cm x 20 cm field at the calibration depth were included. The transmission under these two conditions was compared with that under reference conditions. The relative transmission values for 138 photon beams from 88 separate linear accelerators (4-25 MV) and 60Co units were measured. Our data suggest that the dependence of the wedge transmission on field-size and depth, in the first approximation, depends on the absolute value of the transmission under reference conditions. For wedges with a transmission value greater than 0.65%, field-size dependence and change in depth dose are typically less than 2%. However, for wedges with transmission values less than 0.65%, field-size dependence increases with decreasing reference wedge transmission. The change in wedge transmission with depth is significant (> 2%) only for photon energies less than or equal to 10 MV and can exceed 5% for thick wedges. Failure to include the depth and field-size dependencies of wedge transmission in patient dosimetry calculations can result in significant tumor-dose discrepancies.
Assuntos
Radiometria/métodos , Fenômenos Biofísicos , Biofísica , Humanos , Neoplasias/radioterapia , Aceleradores de Partículas , Fótons , Radiometria/normas , Radiometria/estatística & dados numéricos , Planejamento da Radioterapia Assistida por Computador/métodos , Planejamento da Radioterapia Assistida por Computador/estatística & dados numéricos , Radioterapia de Alta Energia , Padrões de ReferênciaRESUMO
The device developed by the authors and described here enables the user to measure the depth from the water surface to the point of measurement for a cylindrical ion chamber with a waterproof plastic cap in a water phantom, free of surface-tension error with a high precision. The device seeks vertical orientation and provides the convenience of hands-free operation. The measurement process is simple and quick with a precision of 0.1 mm. (The device is currently available as a 'water phantom depth gauge' from Nuclear Associates, Division of Victoreen Inc., Clare Place, NY, USA.)
Assuntos
Radiometria/instrumentação , Fenômenos Biofísicos , Biofísica , Humanos , Imagens de Fantasmas , ÁguaRESUMO
The water equivalency of five "water-equivalent" solid phantom materials was evaluated in terms of output calibration and energy characterization over a range of energies for both photon (Co-60 to 24 MV) and electron (6-20 MeV) beams. Evaluations compared absorbed doses calculated from ionization measurements using the same dosimeter in the solid phantom materials and in natural water (H2O). Ionization measurements were taken at various calibration depths. The Radiological Physics Center's standard dosimetry system, a Farmer-type ion chamber in a water phantom, was used. Complying with the TG-21 calibration protocol, absorbed doses were calculated using eight measurement and calculational techniques for photons and five for electrons. Results of repeat measurements taken over a period of 2 1/2 years were reproducible to within a +/- 0.3% spread. Results showed that various combinations of measurement techniques and solid phantom materials caused a spread of 3%-4% in the calculation of dose relative to the dose determined from measurements in water for all beam energies on both modalities. An energy dependence of the dose ratios was observed for both photons and electrons.